During the past decade, NBR Polska conducted 10 clinical trials. In the 10-year time frame, 10 clinical trials started and 3 clinical trials were completed, i.e. on average, 30% percent of trials that started reached the finish line to date. In the past 5 years, 7 clinical trials started and 2 clinical trials were completed. i.e. 28.6% of trials that started reached the finish line.

Out of the total clinical trials conducted in "NBR Polska" #1 sponsor was "Boehringer Ingelheim" with 4 trials, followed by "Eli Lilly and Company" with 2 trials sponsored, "Anji Pharma" with 1 trials sponsored, "Aziende Chimiche Riunite Angelini Francesco S.p.A" with 1 trials sponsored and "Bayer" with 1 trials sponsored. Other sponsors include -3 different institutions and companies that sponsored additional 7 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "NBR Polska" #1 collaborator was "Eli Lilly and Company" with 2 trials as a collaborator, "Brigham and Women's Hospital" with 1 trials as a collaborator and "Chiltern International Inc." with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 3 trials.

According to Clinical.Site data, the most researched conditions in "NBR Polska" are "Diabetes Mellitus, Type 2" (3 trials), "Atrial Fibrillation" (1 trials), "Diabetes" (1 trials), "Diabetes Mellitus, Type 1" (1 trials) and "Diabetic Nephropathies" (1 trials). Many other conditions were trialed in "NBR Polska" in a lesser frequency.

Most popular intervention types in "NBR Polska" are "Drug" (11 trials) and "Other" (2 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (8 trials), "Apixaban" (1 trials), "Apixaban matching placebo" (1 trials), "Asundexian (BAY2433334)" (1 trials) and "Asundexian matching placebo" (1 trials). Other intervention names were less common.

The vast majority of trials in "NBR Polska" are 11 trials for "All" genders.

Currently, there are NaN active trials in "NBR Polska". undefined are not yet recruiting, 2 are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 5 completed trials in NBR Polska, 1 suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in NBR Polska, 0 "Phase 1" clinical trials were conducted, 4 "Phase 2" clinical trials and 6 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".